Congress Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-66,678
Closed -$10.2M 375
2021
Q1
$10.2M Sell
66,678
-2,848
-4% -$441K 0.09% 125
2020
Q4
$10.9M Buy
69,526
+1,295
+2% +$166K 0.1% 110
2020
Q3
$7.81M Buy
68,231
+16,478
+32% +$1.78M 0.08% 135
2020
Q2
$5.81M Buy
51,753
+1,780
+4% +$189K 0.07% 145
2020
Q1
$4.49M Buy
49,973
+5,470
+12% +$537K 0.07% 152
2019
Q4
$4.81M Sell
44,503
-3,090
-6% -$330K 0.06% 171
2019
Q3
$4.66M Buy
47,593
+1,638
+4% +$185K 0.06% 179
2019
Q2
$6.02M Buy
45,955
+1,054
+2% +$136K 0.08% 156
2019
Q1
$6.07M Buy
44,901
+5,237
+13% +$651K 0.08% 148
2018
Q4
$3.86M Sell
39,664
-3,951
-9% -$467K 0.06% 192
2018
Q3
$6.06M Buy
43,615
+1,248
+3% +$157K 0.08% 159
2018
Q2
$5.26M Sell
42,367
-4,411
-9% -$516K 0.07% 164
2018
Q1
$5.21M Buy
46,778
+6,412
+16% +$766K 0.07% 164
2017
Q4
$4.83M Buy
40,366
+1,338
+3% +$163K 0.07% 166
2017
Q3
$5.47M Buy
39,028
+1,526
+4% +$207K 0.08% 150
2017
Q2
$4.56M Buy
37,502
+5,614
+18% +$653K 0.08% 155
2017
Q1
$3.87M Sell
31,888
-4,250
-12% -$548K 0.07% 162
2016
Q4
$4.42M Buy
36,138
+1,132
+3% +$139K 0.09% 149
2016
Q3
$4.29M Buy
35,006
+481
+1% +$61.9K 0.09% 146
2016
Q2
$4.03M Buy
34,525
+2,238
+7% +$318K 0.09% 143
2016
Q1
$4.5M Buy
32,287
+913
+3% +$134K 0.11% 131
2015
Q4
$5.99M Buy
31,374
+1
+0% +$175 0.15% 114
2015
Q3
$4.91M Buy
31,373
+1,012
+3% +$185K 0.13% 125
2015
Q2
$5.49M Sell
30,361
-259
-0.8% -$44.7K 0.16% 125
2015
Q1
$5.31M Sell
30,620
-69
-0.2% -$12.5K 0.13% 123
2014
Q4
$5.68M Sell
30,689
-631
-2% -$117K 0.14% 117
2014
Q3
$5.19M Sell
31,320
-190
-0.6% -$31.2K 0.13% 122
2014
Q2
$4.92M Buy
31,510
+14
+0% +$2.21K 0.13% 124
2014
Q1
$4.79M Buy
31,496
+5,236
+20% +$833K 0.12% 121
2013
Q4
$3.49M Buy
26,260
+375
+1% +$45K 0.09% 139
2013
Q3
$3.01M Buy
+25,885
New +$2.84M 0.08% 148

Other funds holding ALXN